MISSISSAUGA, Ontario,
May 23, 2017 /PRNewswire/
-- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX:
ARZ), a global specialty pharmaceutical company, today
announced the executive management will participate in the
Jefferies Healthcare Conference to be held June 6-9, 2017 in New
York. Adrian Adams, Chief
Executive Officer, will provide an overview of the Company at
8:30 a.m. local time on Wednesday, June 7, 2017.
A live webcast and audio archive for the event may be accessed
from the Investors section of the Aralez website at www.aralez.com.
Please connect to the website prior to the start of the
presentation to ensure adequate time for any software downloads
that may be necessary to listen to the webcast.
About Aralez Pharmaceuticals Inc.
Aralez
Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global
specialty pharmaceutical company focused on delivering meaningful
products to improve patients' lives while creating shareholder
value by acquiring, developing and commercializing products
primarily in cardiovascular, pain and other specialty areas.
Aralez's Global Headquarters is in Ontario, Canada, the US Headquarters is in
Princeton, New Jersey and the
Irish Headquarters is in Dublin,
Ireland. More information about Aralez can be found at
www.aralez.com.
Contact Information:
Aralez Pharmaceuticals US
Inc.
Nichol Ochsner
Executive Director,
Investor Relations & Corporate Communications
732.754.2545
nochsner@aralez.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aralez-to-present-at-the-jefferies-healthcare-conference-300461574.html
SOURCE Aralez Pharmaceuticals Inc.